Paper 80 - THE PET-RPS STUDY: A PROSPECTIVE EVALUATION OF PET-MR IN PREDICTING RESPONSE TO PREOPERATIVE CHEMOTHERAPY FOR PRIMARY RETROPERITONEAL SARCOMA (RPS)

Author(s)

• 

  Deanna Ng, MD, PhD

  General Surgery Resident
  University of Toronto
  Toronto, Ontario, Canada

  Slides

Co-Author(s)

• WJ

  Wendy Johnston, PhD (she/her/hers)

  Sarcoma Clinical Research Manager
  Department of Surgery, Mount Sinai Hospital, Toronto, ON, Canada
  Toronto, Ontario, Canada
• AA

  Albiruni Ryan Abdul Razak, MB BCh, BM BCh

  Princess Margaret Cancer Center
  Toronto, Ontario, Canada
• 

  Rebecca Gladdy, MD, PhD (she/her/hers)

  Surgical Oncologist Clinician-Scientist Associate Professor of Surgery
  Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON
  Toronto, Ontario, Canada
• 

  Abha Gupta, MD MSc

  Staff Oncologist
  Princess Margaret Cancer Center
  Toronto, Ontario, Canada
• PV

  Patrick Veit-Haibach, MD

  University Health Network
  Toronto, Ontario, Canada
• FD

  Fahima Dossa, MD, PhD

  Clinical Fellow
  Memorial Sloan Kettering Cancer Center
  New York, New York, United States
• 

  Geoffrey Watson, MD

  Medical Oncologist
  Mount Sinai Hospital / University of Toronto
  Toronto, Ontario, Canada
• 

  Savtaj Brar, M.Sc., MD (he/him/his)

  Assistant Professor of Surgery
  Mount Sinai Hospital
  Toronto, Ontario, Canada
• UM

  Ur Metser, MD

  University of Toronto
  Toronto, Ontario, Canada
• CS

  Carol Swallow, MD, PhD

  Mount Sinai Hospital, Toronto, ON, Canada
  Toronto, Ontario, Canada